Found: 15
Select item for more details and to access through your institution.
Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 6, p. 12159, doi. 10.3390/ijms160612159
- By:
- Publication type:
- Article
Characterization of KRAS Mutational Regression in Oligometastatic Patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.898561
- By:
- Publication type:
- Article
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0952-7
- By:
- Publication type:
- Article
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921989223
- By:
- Publication type:
- Article
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921989223
- By:
- Publication type:
- Article
Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies.
- Published in:
- Journal of Peptide Science, 2014, v. 20, n. 4, p. 270, doi. 10.1002/psc.2614
- By:
- Publication type:
- Article
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1827, doi. 10.3390/cancers15061827
- By:
- Publication type:
- Article
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1952, doi. 10.3390/cancers12071952
- By:
- Publication type:
- Article
CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.591386
- By:
- Publication type:
- Article
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 4, p. 1, doi. 10.1038/s41419-020-2480-6
- By:
- Publication type:
- Article
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41419-019-1796-6
- By:
- Publication type:
- Article
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 12, p. 2016, doi. 10.1038/s41416-024-02702-x
- By:
- Publication type:
- Article
Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 232, doi. 10.1186/1479-5876-10-232
- By:
- Publication type:
- Article
Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 44, p. 10113, doi. 10.1002/chem.202002468
- By:
- Publication type:
- Article